Event Details
October 01, 2019
Description
European Commission expected to release a draft act to authorize CBD (future tense in document).
Participants (1)
| Name | Type | Mentions | |
|---|---|---|---|
| European Commission | person | 2 | View Entity |
Source Documents (1)
HOUSE_OVERSIGHT_024896.jpg
This document is page 80 of a financial research report produced by Cowen, dated February 25, 2019, analyzing the regulatory landscape for medical cannabis and CBD in Europe. It details the European Parliament's non-binding resolution to harmonize cannabis policies, compares THC limits between the EU (0.2%) and North America (0.3%), and discusses the classification of CBD within the 'Novel Food Catalogue.' The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation.
Related Events
Events with shared participants
The European Commission is expected to make a final decision on the Marketing Authorization Application for Praluent in the European Union.
2015-09-01 • European Union
UN-sponsored donors conference on Yemen
2017-05-01 • Geneva
Expected final decision by European Commission on Marketing Authorization Application
2015-09-01 • European Union
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein event